Description
PHARMACEUTICALS FOR NUCLEAR MEDICINE
First action · last action
2011-08-31 · 2011-08-31
Transactions
1
First transaction's obligation
$24,171
Base + all options value (sum of deltas)
$24,171
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P5890X
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-08-31+$24,171= $24,171
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-08-31 | +$24,171 | $24,171 | PHARMACEUTICALS FOR NUCLEAR MEDICINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NKGHPQKJQWC1)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36E79722A0001 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2022 |
| 36F79721D0260 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2021 |
| 36E79719A0025 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2019 |
| VA24817F2692 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $145,897 | FY2017 |
| VA24817F2026 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $243,162 | FY2017 |
| VA24817F0523 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $243,162 | FY2017 |
Other recipients under 6505 from 689-WEST HAVEN (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24112P1253 | CENTRAL ADMIXTURE PHARMACY SERVICES, INC | 689-WEST HAVEN | $31,406 | FY2012 |
| VA689A10884 | ASD SPECIALTY HEALTHCARE, LLC | 689-WEST HAVEN | $19,966 | FY2011 |
| VA689A10863 | ROCHE DIAGNOSTICS CORPORATION | 689-WEST HAVEN | $24,477 | FY2011 |
| VA689A10840 | NORDION (CANADA) INC. | 689-WEST HAVEN | $10,540 | FY2011 |
| VA689A10811 | BAYER HEALTHCARE PHARMACEUTICALS LIMITED LIABILITY COMPANY | 689-WEST HAVEN | $12,915 | FY2011 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA689A10849_3600_V797P5890X_3600 · retrieved 2026-09-26.